Consolidation Trends within Infusion Therapy
Published May 2024
Infusion therapy stands as a crucial alternative to oral treatments, primarily used for serious or chronic infections unresponsive to oral medications. This therapeutic approach takes place in hospitals, infusion therapy centers, and homes, with specialized professionals, such as nurses, administering medication.
Covering a wide range of medical conditions, from cancer to gastrointestinal disorders, chronic pain, and immune system deficiencies, infusion therapy finds applications in treating illnesses like rheumatoid arthritis, Crohn’s disease, hemophilia, and multiple sclerosis. The diverse applications present lucrative growth opportunities for companies, propelling the overall infusion therapy market. Industry tailwinds include the increasing prevalence of chronic pain, cancer, and diabetes, along with government investments to modernize healthcare infrastructure have led to a heightened demand for infusion therapy services. The surge in chronic diseases across the U.S. further contributes to the growth of the overall infusion therapy market, classified into Traditional (Acute) and Specialty Infusion (Chronic) therapeutic classes.
Leveraging its thorough research and industry insights, Provident Healthcare Partners (“Provident”), examines the consolidation trends and competitive landscape within the infusion therapy space. The whitepaper will also cover key topics such as valuation expectations, partnership considerations, and evolving industry growth drivers.
Whitepaper Summary:
- Introduction
- Overview of Care Settings
- Industry Growth Drivers
- Industry Headwinds
- Infusion Therapy Market Landscape
- Characteristics of Leading Infusion Platforms
- Partnership Considerations
- Select Recent Platform Transaction Activity
- Conclusion
